alpha-fetoprotein-derived antigen-based HIV vaccine (Canopus)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug Namealpha-fetoprotein-derived antigen-based HIV vaccine (Canopus)
Drug Alias NameN/A
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionAlpha-fetoprotein modulators
TargetsAlpha-fetoprotein
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCanopus BioPharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCanopus BioPharma Inc
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A